共查询到20条相似文献,搜索用时 15 毫秒
1.
Loek T. M. van Wandelen Dr. Jeroen van Ameijde Ahmed S. A. Mady Angelique E. M. Wammes Alois Bode Dr. Alex J. Poot Dr. Rob Ruijtenbeek Prof. Dr. Rob M. J. Liskamp 《ChemMedChem》2012,7(12):2113-2121
Kinases present an attractive target for drug development, since they are involved in vital cellular processes and are implicated in a variety of diseases, such as cancer and diabetes. However, obtaining selectivity for a specific kinase over others is difficult since many current kinase inhibitors exclusively target the highly conserved kinase ATP binding domain. Previously, a microarray‐based strategy to discover so‐called bisubstrate‐based inhibitors that target the more specific peptide binding groove in addition to the ATP binding site was described. One attractive feature of this strategy is the opportunity to tune the selectivity of these inhibitors by systematically varying components. In an extension to this previous work, this study explores the potential of this guided selectivity modulation, leading to a series of inhibitors with different selectivity profiles against highly homologous protein kinase C (PKC) isozymes. Of the inhibitors studied, most exhibited improved potency and selectivity compared with their constituent parts. Furthermore, the selectivity was found to be tunable either through modification of the pseudosubstrate peptide (peptide binding groove) or the ATP‐competitive part (ATP binding site). In a number of cases, the selectivity of the construct could be predicted from the initial peptide substrate profiling experiment. Since this strategy is applicable to all kinase sets, it could be used to rapidly develop uniquely selective inhibitors. 相似文献
2.
Alex J. Poot Jeroen van Ameijde Dr. Monique Slijper Dr. Adriënne van den Berg Riet Hilhorst Dr. Rob Ruijtenbeek Dr. Dirk T. S. Rijkers Dr. Rob M. J. Liskamp Prof. Dr. 《Chembiochem : a European journal of chemical biology》2009,10(12):2042-2051
Kinase inhibitors are increasingly important in drug development. Because the majority of current inhibitors target the conserved ATP‐binding site, selectivity might become an important issue. This could be particularly problematic for the potential drug target protein kinase C (PKC), of which twelve isoforms with high homology exist in humans. A strategy to increase selectivity is to prepare bisubstrate‐based inhibitors that target the more selective peptide‐binding site in addition to the ATP‐binding site. In this paper a generally applicable, rapid methodology is presented to discover such bisubstrate‐based leads. Dynamic peptide microarrays were used to find peptide‐binding site inhibitors. These were linked with chemoselective click chemistry to an ATP‐binding site inhibitor, and this led to novel bisubstrate structures. The peptide microarrays were used to evaluate the resulting inhibitors. Thus, novel bisubstrate‐based inhibitors were obtained that were both more potent and selective compared to their constituent parts. The most promising inhibitor has nanomolar affinity and selectivity towards PKCθ amongst three isozymes. 相似文献
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
Hartmut Schirok Dr. Raimund Kast Dr. Santiago Figueroa‐Pérez Dr. Samir Bennabi Dr. Mark J. Gnoth Dr. Achim Feurer Dr. Heike Heckroth Dr. Michael Thutewohl Dr. Holger Paulsen Dr. Andreas Knorr Dr. Joachim Hütter Dr. Mario Lobell Dr. Klaus Münter Dr. Volker Geiß Dr. Heimo Ehmke Prof. Dr. Dieter Lang Dr. Martin Radtke Dr. Joachim Mittendorf Dr. Johannes‐Peter Stasch Dr. 《ChemMedChem》2008,3(12):1797-1797
14.
15.
16.
17.
18.
Influence of the Multivalency of Ultrashort Arg‐Trp‐Based Antimicrobial Peptides (AMP) on Their Antibacterial Activity 下载免费PDF全文
Barbara C. Hoffknecht Dennis J. Worm Sandra Bobersky Pascal Prochnow Prof. Dr. Julia E. Bandow Prof. Dr. Nils Metzler‐Nolte 《ChemMedChem》2015,10(9):1564-1569
Peptide dendrimers are a class of molecules of high interest in the search for new antibiotics. We used microwave‐assisted, copper(I)‐catalyzed alkyne–azide cycloaddition (CuAAC; “click” chemistry) for the simple and versatile synthesis of a new class of multivalent antimicrobial peptides (AMPs) containing solely arginine and tryptophan residues. To investigate the influence of multivalency on antibacterial activity, short solid‐phase‐ synthesized azide‐modified Arg‐Trp‐containing peptides were “clicked” to three different alkyne‐modified benzene scaffolds to access scaffolds with one, two, or three peptides. The antibacterial activity of 15 new AMPs was investigated by minimal inhibitory concentration (MIC) assays on five different bacterial strains, including a multidrug‐resistant Staphylococcus aureus (MRSA) strain. With ultrashort (2–3 residues) peptides, a clear synergistic effect of the trivalent display was observed, whereas this effect was not apparent with longer peptides. The best candidates showed activities in the low‐micromolar range against Gram‐positive MRSA. Surprisingly, the best activity against Gram‐negative Acinetobacter baumannii was observed with an ultrashort dipeptide on the trivalent scaffold (MIC: 7.5 μM ). The hemolytic activity was explored for the three most active peptides. At concentrations ten times the MIC values, <1 % hemolysis of red blood cells was observed. 相似文献
19.